Close Menu

NEW YORK — Molecular diagnostics firm Lucira Health said on Tuesday that it has received $11.5 million to support its development of an over-the-counter influenza test under the second phase of a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.